StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.17+0.51 (+19.17%)

Close on Nov 18, 2026Market cap $117.87MP/E –Yield –

Armata Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Armata Pharmaceuticals's price to sales ratio was 204.9× on Jul 31, 2015.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jul 31, 2015204.9×–

More Armata Pharmaceuticals figures

See a number that looks wrong?